Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Hongene Biotechnology Signs License Agreement with Marina Biotech

publication date: Sep 28, 2015
Hongene Biotechnology, a China manufacturer of nucleosides and nucleotides in China, signed a strategic license agreement with Marina Biotech of the US, a leading nucleic acid-based drug discovery and development company focused on rare diseases. Hongene will have the exclusive right to develop, supply and commercialize certain oligonucleotide constructs using Marina’s Conformationally Restricted Nucleotide (CRN) Chemistry. The agreement, in turn, calls for Hongene to pay Marina Biotech royalties from the sale of CRN-based oligonucleotide reagents and to provide a stable supply of CRN-based oligonucleotides to Marina, which will be used for Marina and its partners’ drug development and commercialization. More details....

Stock Symbol: (OTCQB: MRNA)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital